Human Longevity

Transforming Longevity Through Personalized Medicine

Employees
51–200
Business Model
B2C
Total Funding
$369.8M
Last Round
$39.8M Series BAug 2024
Rounds
4

About

Human Longevity is a precision medicine company that integrates genomics, whole-body MRI, microbiome analysis, and clinical data to detect life-threatening conditions before symptoms appear. Founded in 2013 by J. Craig Venter, the company operates longevity clinics in San Diego, San Francisco, and Beijing offering comprehensive executive health assessments. It has published 20+ peer-reviewed papers and is ranked among the top 50 biomedical companies globally by Nature Index.

Summary

Human Longevity is a Biotech company based in San Diego, United States. It has raised $369.8M in total across 4 rounds, most recently a $39.8M Series B round in Aug 2024. Investors include Celgene Corp, Illumina Ventures and GE Ventures.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Series BSeries BAug 2024
$39.8M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Create Free Account

Investors

Similar Companies